PIRCHE
Pirche is a health tech company revolutionizing transplant medicine and immunotherapy with its digital epitope matching technology. Their flagship platform, TxPredictor, leverages advanced algorithms and AI-driven simulations to provide precise donor-recipient compatibility assessments at the epitope level. This technology goes beyond traditional HLA matching by focusing on the critical peptide binding properties of HLA molecules, predicting immune responses and minimizing risks like Graft versus Host Disease. Pirche's platform is backed by extensive research, over 80 publications, and has been validated across various transplant types. They offer a cloud-based, SaaS solution that integrates with existing lab systems, providing real-time analysis and clear user interfaces for clinicians. The company has established global partnerships and a strong intellectual property portfolio, aiming to improve transplant outcomes and patient quality of life.
PIRCHE
Pirche is a health tech company revolutionizing transplant medicine and immunotherapy with its digital epitope matching technology. Their flagship platform, TxPredictor, leverages advanced algorithms and AI-driven simulations to provide precise donor-recipient compatibility assessments at the epitope level. This technology goes beyond traditional HLA matching by focusing on the critical peptide binding properties of HLA molecules, predicting immune responses and minimizing risks like Graft versus Host Disease. Pirche's platform is backed by extensive research, over 80 publications, and has been validated across various transplant types. They offer a cloud-based, SaaS solution that integrates with existing lab systems, providing real-time analysis and clear user interfaces for clinicians. The company has established global partnerships and a strong intellectual property portfolio, aiming to improve transplant outcomes and patient quality of life.